Pei J - Search Results

1

Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data.

Gale S, Trinh H, Tuckwell K, Collinson N, Stone JH, Sarsour K, Pei J, Best J, Birchwood C, Mohan SV. Gale S, et al. Among authors: pei j. Rheumatol Ther. 2019 Mar;6(1):77-88. doi: 10.1007/s40744-019-0139-5. Epub 2019 Feb 1. Rheumatol Ther. 2019. PMID: 30707391 Free PMC article.

2

Long-Term Safety and Efficacy of Subcutaneously Administered Tocilizumab for Adult Rheumatoid Arthritis: A Multicenter Phase 3b Long-term Extension Study.

Kivitz A, Wallace T, Olech E, Borofsky M, Devenport J, Pei J, Michalska M. Kivitz A, et al. Among authors: pei j. Rheumatol Ther. 2016 Dec;3(2):291-304. doi: 10.1007/s40744-016-0043-1. Epub 2016 Sep 24. Rheumatol Ther. 2016. PMID: 27747585 Free PMC article.

3

Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis.

Soubrier M, Pei J, Durand F, Gullestad L, John A. Soubrier M, et al. Among authors: pei j. Rheumatol Ther. 2017 Jun;4(1):133-149. doi: 10.1007/s40744-016-0049-8. Epub 2016 Nov 29. Rheumatol Ther. 2017. PMID: 27900570 Free PMC article.

4

Low immunogenicity of tocilizumab in patients with rheumatoid arthritis.

Burmester GR, Choy E, Kivitz A, Ogata A, Bao M, Nomura A, Lacey S, Pei J, Reiss W, Pethoe-Schramm A, Mallalieu NL, Wallace T, Michalska M, Birnboeck H, Stubenrauch K, Genovese MC. Burmester GR, et al. Among authors: pei j. Ann Rheum Dis. 2017 Jun;76(6):1078-1085. doi: 10.1136/annrheumdis-2016-210297. Epub 2016 Dec 22. Ann Rheum Dis. 2017. PMID: 28007755 Free article.

5

Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials.

Strand V, Michalska M, Birchwood C, Pei J, Tuckwell K, Finch R, Gabay C, Kavanaugh A, Jones G. Strand V, et al. Among authors: pei j. RMD Open. 2017 Sep 14;3(2):e000496. doi: 10.1136/rmdopen-2017-000496. eCollection 2017. RMD Open. 2017. PMID: 28955499 Free PMC article.

6

Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis.

Kivitz A, Olech E, Borofsky MA, Zazueta B, Navarro-Sarabia F, Radominski SC, Merrill JT, Pacheco-Tena C, Pei J, Nasmyth-Miller C, Pope JE. Kivitz A, et al. Among authors: pei j. J Rheumatol. 2018 Apr;45(4):456-464. doi: 10.3899/jrheum.161539. Epub 2017 Dec 15. J Rheumatol. 2018. PMID: 29247149 Free article. Clinical Trial.

7

Sustained Response Following Discontinuation of Methotrexate in Patients With Rheumatoid Arthritis Treated With Subcutaneous Tocilizumab: Results From a Randomized, Controlled Trial.

Kremer JM, Rigby W, Singer NG, Birchwood C, Gill D, Reiss W, Pei J, Michalska M. Kremer JM, et al. Among authors: pei j. Arthritis Rheumatol. 2018 Aug;70(8):1200-1208. doi: 10.1002/art.40493. Epub 2018 Jun 14. Arthritis Rheumatol. 2018. PMID: 29575803 Clinical Trial.

8

Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis.

Strand V, Michalska M, Birchwood C, Pei J, Tuckwell K, Finch R, Kivitz AJ, Smolen JS, Burmester GR. Strand V, et al. Among authors: pei j. RMD Open. 2018 Jun 17;4(1):e000602. doi: 10.1136/rmdopen-2017-000602. eCollection 2018. RMD Open. 2018. PMID: 29955380 Free PMC article.

9

Magnetic Resonance Imaging (MRI) Results Following Discontinuation of Methotrexate in Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab: The COMP-ACT MRI Substudy.

Peterfy C, Kremer J, Rigby W, Singer N, Birchwood C, Gill D, Reiss W, Pei J, Michalska M. Peterfy C, et al. Among authors: pei j. J Rheumatol. 2020 Mar;47(3):325-332. doi: 10.3899/jrheum.180953. Epub 2019 Jun 1. J Rheumatol. 2020. PMID: 31154414 Free article. Clinical Trial.

10

Comparative Cost per Response for 4 Clinical Endpoints with Tocilizumab Monotherapy vs Adalimumab Monotherapy in a Head-to-Head Randomized Double-Blind Superiority Trial (ADACTA) in Patients with Rheumatoid Arthritis.

Best JH, Vlad SC, Pei J. Best JH, et al. Among authors: pei j. Rheumatol Ther. 2020 Mar;7(1):165-171. doi: 10.1007/s40744-019-00191-6. Epub 2020 Jan 6. Rheumatol Ther. 2020. PMID: 31907758 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,543 results

Search Page